一个综合的专业间持续医学教育和质量改善倡议,以解决2型糖尿病患者的心血管和脏风险在社区基础的初级保健实践中
Patrice Lazure1, Kevin M Pantalone2, Bethany Frampton2
1AXDEV Group, Montreal, QC, Canada.
Journal of CME
|October 17, 2025
概括
一项质量改善和持续医学教育干预 (QICMEi) 改善了2型糖尿病患者的初级保健提供者的知识和团队合作. 然而,由于系统障碍,它对处方SGLT-2i/GLP-1RA药物的影响很小.
科学领域:
- 主要护理医学 医疗保健
- 医学教育 医学教育
- 提高质量 提高科学 提高质量
背景情况:
- 2型糖尿病的管理需要专业间的初级保健提供者 (PCP) 能力,特别是在心血管和慢性病风险方面.
- SGLT-2抑制剂 (SGLT-2i) 和GLP-1受体激动剂 (GLP-1RA) 对于管理这些并发症至关重要.
- 现有的护理缺口需要进行干预,以提高PCP的性能和患者的治疗结果.
研究的目的:
- 为跨专业PCP开发和实施质量改善和持续医学教育干预 (QICMEi).
- 为了提高PCP能力,表现和患者护理结果,对于患有心血管或慢性病风险的2型糖尿病患者.
- 评估QICMEi对治疗选择,坚持和系统级护理服务的影响.
主要方法:
- 在一个集成的交付系统中,QICMEi在两个社区家庭健康中心实施.
- 干预设计涉及EHR数据分析,干预前评估和基于团队的质量改进 (QI) 讨论.
- 通过学习者调查,采访和对处方模式的EHR数据分析来评估结果.
主要成果:
- PCP在治疗选择方面表现出更多的知识,能力和表现,感知到的挑战减少.
- 患者教育材料和EHR工具的持续使用,增强了患者的沟通.
- 电子健康记录数据仅显示SGLT-2i/GLP-1RA处方模式的轻微,非临床显著变化.
结论:
- 该QICMEi成功地提升了PCP知识,表现,团队合作和护理系统.
- 处方模式的重大变化受到高基准水平和系统性障碍 (如保险授权和药物成本) 的阻碍.
- 需要进一步的研究来完善QICMEi策略,以持续,社区层面的变化提供者治疗模式.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
237
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
237
01:28Chronic Kidney Disease III: Interprofessional Care
335
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
335
01:27Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212
01:29Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
01:20Acute Kidney Injury V: Interprofessional Care
295
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
295
01:28Acute Coronary Syndrome IV: Interprofessional Care
216
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
216